MedTrace Logo

SpyGlass™ Discover Percutaneous

NCT04580940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-11-29

No results posted yet for this study

Summary

To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series

Conditions

Interventions

DEVICE

SpyGlass™ Discover Digital System

Observational, prospective, registry study for the clinical utility of the SpyGlass Discover digital catheter during a PTCS procedure.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Ivo Boskoski, MD, PhD · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

  • Torsten Beyna, MD, PhD · Evangelisches Krakenhaus Düsseldorf

  • Mehran Fotoohi, MD, PhD · Virginia Mason

  • Arnaud Lemmers, MD, PhD · Erasme University Hospital

  • James Lau, MD, PhD · Prince of Wales Hospital

  • Eran Shlomovitz, MD, PhD · Toronto General Hospital, University Health Network

  • Mohan Ramchandani, MD, PhD · Asian Institute of Gastroenterology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2022-12-14
Completion
2023-01-14
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Canada
  • Germany
  • Hong Kong
  • India
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04580940 on ClinicalTrials.gov